Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants

Current Opinion in Infectious Diseases

Volumn 26, Issue 3, 2013, Pages 248-253

  Lindsey, Benjamin ^a   Kampmann, Beate ^a,b   Jones, Christine ^a,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

maternal immunization; neonatal infection; pregnancy; vaccination

Indexed keywords

INFLUENZA VACCINE; PERTUSSIS VACCINE;

HUMAN; IMMUNIZATION; INFECTION RISK; INFECTION SENSITIVITY; INFLUENZA; MATERNAL TREATMENT; NEWBORN INFECTION; PERTUSSIS; PREGNANCY; REVIEW; RISK REDUCTION; TREATMENT INDICATION;

FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT, NEWBORN; INFLUENZA, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; VACCINES; WHOOPING COUGH;

EID: 84876869957     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3283607a58     Document Type: Review

References (53)

1. Jones C, Naidoo S, De Beer C, et al. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 2011; 305:576-584.
2. Palmeira P, Quinello C, Silveira-Lessa A, et al. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012; 2012:985646.
3. Saji F, Samejima Y, Kamiura S, Koyama M. Dynamics of immunoglobulins at the feto-maternal interface. Rev Reprod 1999; 4:81-89.
4. Healy CM. Vaccines in pregnant women and research initiatives. Clin Obstet Gynecol 2012; 55:474-486.
5. Leuridan E, Hens N, Peeters N, et al. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011; 30:608-610.
6. van den Berg J, Westerbeek E, Berbers G, et al. Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, Haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants. Pediatr Infect Dis J 2010; 29:801- 805.
7. de Moraes-Pinto MI, Verhoeff F, Chimsuku L, et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 1998; 79:F202-F205.
8. Farquhar C, Nduati R, Haigwood N, et al. High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody. J Acquir Immune Defic Syndr 2005; 40:494-497.
9. Galbraith RM, Fox H, Hsi B, et al. The human materno-foetal relationship in malaria. II. Histological, ultrastructural and immunopathological studies of the placenta. Trans R Soc Trop Med Hyg 1980; 74:61-72.
10. Bjorkholm B, Granstrom M, Taranger J, et al. Influence of high titers of maternal antibody on the serologic response of infants to diphtheria vaccination at three, five and twelve months of age. Pediatr Infect Dis J 1995; 14:846-850.
11. Slack MH, Schapira D, Thwaites RJ, et al. Acellular pertussis vaccine given by accelerated schedule: response of preterm infants. Arch Dis Child Fetal Neonatal Ed 2004; 89:F57-F60.
12. Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003; 21:3406-3412.
13. Englund JA, Anderson EL, Reed GF, et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995; 96:580-584.
14. Brent RL. Risks and benefits of immunizing pregnant women: the risk of doing nothing. Reprod Toxicol 2006; 21:383-389.
15. Castillo-Solorzano C, Reef SE, Morice A, et al. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008. J Infect Dis 2011; 204:S713-S717.
16. Moro PL, Broder K, Zheteyeva Y, et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol 2011; 204:146.e1-146.e7.
17. Nasidi A, Monath TP, Vandenberg J, et al. Yellow fever vaccination and pregnancy: a four-year prospective study. Trans R Soc Trop Med Hyg 1993; 87:337-339.
18. Zheteyeva YA, Moro PL, Tepper NK, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012; 207:59.e1-59.e7.
19. Tamma PD, Ault KA, del Rio C, et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2009; 201:547-552.
20. Oppermann M, Fritzsche J, Weber-Schoendorfer C, et al. A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine 2012; 30:4445-4452.
21. Pasternak B, Svanstrom H, Molgaard-Nielsen D, et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA 2012; 308:165-174.
22. Sheffield JS, Greer LG, Rogers VL, et al. Effect of influenza vaccination in the first trimester of pregnancy. Obstet Gynecol 2012; 120:532- 537.
23. Schatz M, Chambers CD, Jones KL, et al. Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System. Am J Obstet Gynecol 2011; 204:S64-S68.
24. Health Protection Agency (HPA). Whooping cough cases remain high - press release. 2012; Available at: http://www.hpa.org.uk/NewsCentre/ NationalPressReleases/2012PressReleases/121221Whoopingcoughcases remainhigh/. [Accessed on 30 December 2012]
25. Campbell H, Amirthalingam G, Andrews N, et al. Accelerating control of pertussis in England and Wales. Emerg Infect Dis 2012; 18:38-47.
26. Health Protection Agency (HPA). Confirmed pertussis in England and Wales: data to end-December 2012. Health Protection Report: 2013. Available at: www.hpa.org.uk/hpr/archives/2013/news0513.htmHASHSYMBOLprtsss. [Accessed 6 March 2013]
27. Department of Health. Pregnant women to be offered whooping cough vaccination. 2012; http://www.dh.gov.uk/health/2012/09/whooping-cough/ . [Accessed on 1 November 2012]
28. Centers for Disease Control and Prevention (CDC). Provisional updated recommendations on the use of tetanus toxoid, reduced diptheria toxoid and acellular pertussis vaccine (Tdap) for pregnant women - Advisory Committee on Immuniation Practices (ACIP). 2012; http:// www.immunize.org/acip/acip-2012.asp. [Accessed on 1 November 2013]
29. Halperin BA, Morris A, Mackinnon-Cameron D, et al. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis 2011; 53:885- 892.
30. Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria- pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011; 204:334e1-334e5.
31. Van Savage J, Decker MD, Edwards KM, et al. Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis 1990; 161:487-492.
32. Pertussis vaccine in healthy pregnant women. Available at: http://clinical trials.gov/show/nct00707148, [Accessed on 1 December 2012]
33. Halperin S. Pertussis maternal immunisation study. http://clinicaltrials. gov/ show/nct00553228, [Accessed on 1 December 2012]
34. Taranger J, Trollfors B, Lagergard T, et al. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis 2000; 181:1010-1013.
35. Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis 2007; 7:614-624.
36. Jamieson DJ, Honein MA, Rasmussen SA, et al. Novel Influenza A (H1N1) Pregnancy Working Group. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451-458.
37. Pierce M, Kurinczuk JJ, Spark P, et al. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ 2011; 342:3214.
38. Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 2011; 205:10-18.
39. Blanchard-Rohner G, Siegrist CA. Vaccination during pregnancy to protect infants against influenza: why and why not? Vaccine 2011; 29:7542- 7550.
40. Jackson LA, Patel SM, Swamy GK, et al. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis 2011; 204:854-863.
41. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359:1555-1564.
42. Phares CR, Lynfield R, Farley MM, et al. Active Bacterial Core Surveillance/ Emerging Infections Program Network. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299:2056- 2065.
43. Jordan HT, FarleyMM,Craig A, et al. Active Bacterial Core Surveillance (ABCs)/ Emerging Infections Program Network,CDC. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 2008; 27:1057-1064.
44. Heath P. An update on vaccination against group B streptococcus. Expert Review 2011; 10:685-694.
45. Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 2012; 379:547-556.
46. Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine 2003; 21:3468-3472.
47. U.S National Institutes of Health. Clinicaltrials.gov. 2012; http://clinicaltrials.- gov/. [Accessed on 1 December 2012]
48. Department of Health. Influenza immunisation uptake monitoring programme, England, winter 2011/12. 2012; http://immunisation.dh.gov.uk/flu-imms-uptake- monitoring-prog-eng-winter-201112/. [Accessed on 1 December 2012]
49. Broughton DE, Beigi RH, Switzer GE, et al. Obstetric healthcare workers' attitudes and beliefs regarding influenza vaccination in pregnancy. Obstet Gynecol 2009; 114:981-987.
50. Panda B, Stiller R, Panda A. Influenza vaccination during pregnancy and factors for lacking compliance with current CDC guidelines. J Matern Fetal Neonat Med 2011; 24:402-406.
51. Meharry P, Colson E, Grizas A, et al. Reasons why women accept or reject the trivalent inactivated influenza vaccine (TIV) during pregnancy. Matern Child Health J 2013; 17:156-164.
52. Fisher BM, Scott J, Hart J, et al. Behaviors and perceptions regarding seasonal and H1N1 influenza vaccination during pregnancy. Am J Obstet Gynecol 2011; 204:S107-S111.
53. Department of Health. Pertussis vaccine uptake in pregnant women, October http://immunisation.dh.gov.uk/pertus-vac-up-preg-women-oct12/. [Accessed on 30 December 2012]